title: Antimicrobial susceptibilities of clinical isolates of HACEK organisms.
abstract: The "HACEK" organisms are a group of fastidious Gram-negative bacteria that cause a variety of infections, including infective endocarditis. Antimicrobial susceptibility testing is not universally available, and therapy for these infections is often empirical. We report the antimicrobial susceptibilities of 70 clinical HACEK isolates to 18 antimicrobials. All isolates were susceptible to ceftriaxone and levofloxacin, indicating that these agents remain appropriate empirical choices for the treatment of infections with this group of organisms.
authors: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
authors: Bryan
authors: B
authors: Coburn
authors: Baldwin
authors: B
authors: Toye
authors: Prasad
authors: P
authors: Rawte
authors: Frances B
authors: FB
authors: Jamieson
authors: David J
authors: DJ
authors: Farrell
authors: Samir N
authors: SN
authors: Patel
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002443:Ceftriaxone / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D064704:Levofloxacin; D008826:Microbial Sensitivity Tests; D015242:Ofloxacin / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D002443:Ceftriaxone; D015242:Ofloxacin
references: J Clin Microbiol. 1998 Dec;36(12):3492-6
references: 9817860
references: Circulation. 2005 Jun 14;111(23):e394-434
references: 15956145
references: J Antimicrob Chemother. 2012 Feb;67(2):269-89
references: 22086858
references: J Antimicrob Chemother. 2001 Feb;47(2):191-3
references: 11157905
references: Eur Heart J. 2009 Oct;30(19):2369-413
references: 19713420
references: Diagn Microbiol Infect Dis. 1999 May;34(1):73-6
references: 10342111
references: Eur J Clin Microbiol Infect Dis. 2001 Apr;20(4):231-6
references: 11399011